- NSE
- ALKEM
- BSE
- 539523
- ISIN
- INE540L01014
ALKEM LABORATORIES
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹5,398.50
+₹101.50 (+1.92%)
NSE close ·
ALKEM LABORATORIES closed at ₹5,398.50 on 9 Nov 2026, up 1.92% on the day, and is down 4.76% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹4,947.00 to ₹5,890.00.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹64,547 Cr
- P/E (TTM)
- 29.9
- Industry P/E
- 35.5
- EPS (TTM)
- ₹180.44
- P/B
- 4.67
- Book value
- ₹1,155.87
- ROE
- 15.6%
- ROCE
- 19.7%
- Debt/equity
- 0.12
- Operating margin
- 16.2%
- Net margin
- 14.3%
- Dividend yield
- 0.98%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Jun 2026 (consolidated). Balance sheet 31 Mar 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +13.52% | +8.66% |
| Net profit | −5.52% | +23.75% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹3,893 Cr | ₹521 Cr | −22.00% | ₹43.49 |
| Mar 2026 | ₹3,803 Cr | ₹251 Cr | −22.11% | ₹19.77 |
| Dec 2025 | ₹3,880 Cr | ₹653 Cr | +1.91% | ₹53.19 |
| Sep 2025 | ₹4,105 Cr | ₹779 Cr | +10.99% | ₹63.99 |
| Jun 2025 | ₹3,508 Cr | ₹668 Cr | +21.39% | ₹55.56 |
| Mar 2025 | ₹3,290 Cr | ₹322 Cr | +5.88% | ₹25.57 |
| Dec 2024 | ₹3,467 Cr | ₹641 Cr | +6.04% | ₹52.34 |
| Sep 2024 | ₹3,549 Cr | ₹702 Cr | +14.16% | ₹57.60 |
Armor risk check
ALKEM LABORATORIES moves about 1.5× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is ALKEM LABORATORIES's share price today?
ALKEM LABORATORIES (NSE: ALKEM) closed at ₹5,398.50 on 9 Nov 2026, up 1.92% from the previous close of ₹5,297.00. It traded between ₹5,312.50 and ₹5,475.00 that day.
What are ALKEM LABORATORIES's 52-week high and low?
Over the last 52 weeks ALKEM LABORATORIES traded between ₹4,811.00 and ₹5,933.50, adjusted for splits and bonuses.
What are ALKEM LABORATORIES's NSE symbol, BSE code and ISIN?
ALKEM LABORATORIES has NSE symbol ALKEM, BSE code 539523, ISIN INE540L01014.
How has ALKEM LABORATORIES performed over 1, 3 and 5 years?
ALKEM LABORATORIES's share price return: 1Y −4.76%, 3Y +8.02% a year, 5Y +8.54% a year. Dividends are not included.
Does ALKEM LABORATORIES pay a dividend?
Yes. ALKEM LABORATORIES's latest dividend went ex on 7 Aug 2026: Final · ₹10.00 per share. Dividends over the past year come to a yield of 0.98% at the latest close.
What is ALKEM LABORATORIES's P/E ratio?
ALKEM LABORATORIES's P/E ratio is 29.9: the ₹5,398.50 close on 9 Nov 2026 over trailing twelve-month EPS of ₹180.44 (consolidated, four quarters to 30 Jun 2026).
What is ALKEM LABORATORIES's market cap?
ALKEM LABORATORIES's market cap is ₹64,547 Cr at the close on 9 Nov 2026.
Which sector is ALKEM LABORATORIES in?
ALKEM LABORATORIES is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how ALKEM LABORATORIES fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app